Alexander disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Alexander disease Classification and external resources | |
| ICD-9 | 331.89 |
|---|---|
| OMIM | 203450 |
|
WikiDoc Resources for Alexander disease | |
|
Articles | |
|---|---|
|
Most recent articles on Alexander disease Most cited articles on Alexander disease | |
|
Media | |
|
Powerpoint slides on Alexander disease | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Alexander disease | |
|
Clinical Trials | |
|
Ongoing Trials on Alexander disease at Clinical Trials.gov Trial results on Alexander disease Clinical Trials on Alexander disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Alexander disease NICE Guidance on Alexander disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Alexander disease Discussion groups on Alexander disease Patient Handouts on Alexander disease Directions to Hospitals Treating Alexander disease Risk calculators and risk factors for Alexander disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Alexander disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Alexander disease is a slowly progressing and fatal neurodegenerative disease. It is a very rare disorder which results from a genetic mutation and mostly affects infants and children, causing developmental delay and changes in physical characteristics.
Synonyms
- Dysmyelogenic leukodystrophy
- Dysmyelogenic leukodystrophy-megalobare
- Fibrinoid degeneration of astrocytes
- Fibrinoid leukodystrophy
- Hyaline panneuropathy
- Leukodystrophy with Rosenthal fibers
- Megalencephaly with hyaline inclusion
- Megalencephaly with hyaline panneuropathy
Clinical features
Delays in development of some physical, psychological and behavioral skills, progressive enlargement of the head (macrocephaly), seizures, spasticity, in some cases also hydrocephalus, dementia, clumsy movements.
Pathology
Alexander disease is a genetic disorder affecting the central nervous system (midbrain and cerebellum). It is caused by mutations in the gene for glial fibrillary acidic protein (GFAP) that maps to chromosome 17q21. It is inherited in an autosomal dominant manner.
Alexander disease belongs to leukodystrophies, a group of diseases which affect growth or development of the myelin sheath. The destruction of white matter in the brain is accompanied by the formation of fibrous, eosinophilic deposits known as Rosenthal fibers.
CT shows:
- decreased density of white matter
- frontal lobe predominance
- +/- dilated lateral ventricles
Cause
The cause of Alexander disease is a mutation in the gene encoding glial fibrillary acidic protein.
Occurrence and prevalence
Very rare. The infantile form (80% of all cases) starts usually at the age of six months or within the first two years. The average duration of the infantile form of the illness is usually about 3 years. Onset of the juvenile form (14% of all cases) presents usually between four to ten years of age. Duration of this form is in most cases about 8 years. In younger patients, seizures, megalencephaly, developmental delay, and spasticity are usually present. Neonatal onset is also reported. Onset in adults is least frequent. In older patients, bulbar or pseudobulbar symptoms and spasticity predominate. Symptoms of the adult form may also resemble multiple sclerosis.
There are no more than 300 cases reported.
Treatment
There is neither cure nor standard treatment for Alexander disease. All treatment is symptomatic and supportive, for example antibiotics for intercurrent infection and anticonvulsants for seizure control are usually used.
Prognosis
The prognosis is generally poor. With early onset, death usually occurs within 10 years after the onset of symptoms. Usually, the later the disease occurs, the slower its course is.
See also
External links
- alexander at NIH/UW GeneTests
- The Stennis Foundation - Registered charity committed to raising awareness and funds for Leukodystrophies research
- The Stennis Foundation's MySpace site
de:Alexander-Krankheit fr:Maladie d'Alexander fi:Aleksanterin tauti
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
